Mashayekhi M

ORCID: 0000-0001-5907-7203 · 7 papers in corpus
observational 2026
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-026-02178-5

GPR30 (G-protein coupled receptor 30) plays a key role in regulating reproductive processes, particularly through estrogen signaling. Previous studies have linked GPR30 polymorphisms to female reproductive disorders such as infertility, rec…

rct 2026
Journal of ovarian research ·doi:10.1186/s13048-026-02012-1

BACKGROUND: There is a clear need for new approaches to help women with low ovarian reserve. A new intervention for women with low ovarian reserve is the intra-ovarian injection of platelet-rich plasma (PRP). It is important to comprehensiv…

rct 2026
International journal of fertility & sterility ·doi:10.22074/ijfs.2025.2054284.1828

OBJECTIVE: Experimental evidence suggests that the human endometrium expresses receptors for human chorionic gonadotropin (hCG), and activation of these receptors may enhance embryo implantation. Numerous studies have explored the effects o…

observational 2025
International journal of reproductive biomedicine ·doi:10.18502/ijrm.v22i11.17819

BACKGROUND: Endometrioma, a common manifestation of endometriosis, often indicates the severity of the disease. In vitro fertilization and embryo transfer (ET) are key therapeutic strategies for infertility associated with endometriosis. Ho…

observational 2024
Journal of ovarian research ·doi:10.1186/s13048-024-01483-4

OBJECTIVE: To compare the ovarian reserve and the results of infertility treatment, as well as to investigate the relapse rate in the first year after the assisted reproductive technology (ART) cycle in patients with multiple sclerosis (MS)…

rct 2024
Scientific reports ·doi:10.1038/s41598-024-77578-1

The studies posits that there is not sufficient evidence to support the use of intrauterine platelet-rich plasma (PRP) infusion in patients with recurrent implantation failure (RIF). This study aims to investigate the effects of infusion of…

nonrandomized-trial 2021
Journal of ovarian research ·doi:10.1186/s13048-020-00743-3

BACKGROUND: Premature ovarian failure (POF) is characterized by the loss of ovarian activity before the age of 40 years. Stem cell therapy has the capability to create a regenerative microenvironment and is a proposed treatment for POF-rela…